Vanberra Signal

Gondola Medical Technologies

Curated by Signal

Developer of a medical device for neurodegenerative disorders

Overview

Developer of a medical device for neurodegenerative disorders. The device is used to measure the motor symptoms of neurodegenerative diseases such as stroke, Parkinson’s, spinal stroke, traumatic brain injury, cerebral palsy, and ataxia. This device provides a non-invasive treatment that interacts with the central nervous system and reduces movement disorder symptoms like walking that includes motor blocks, bradykinesia, freezing of gait, festinating, balance, and speed.

Key facts

Founded
2011

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of an AI based bioinformatics platform for genomic analysis

    Life Sciences TechnologyRolle, Switzerland
  • Provider of device for predicting chances of preterm births

    Life Sciences TechnologyZurich, Switzerland
  • Develops, markets, and supports application services for the management and analysis

    Life Sciences TechnologyLausanne, Switzerland

About Gondola Medical Technologies

What does Gondola Medical Technologies do?

Developer of a medical device for neurodegenerative disorders.

Where is Gondola Medical Technologies headquartered?

Gondola Medical Technologies is headquartered in Epalinges, Switzerland.

When was Gondola Medical Technologies founded?

Gondola Medical Technologies was founded in 2011.

Which sector is Gondola Medical Technologies in?

Gondola Medical Technologies operates in Life Sciences Technology.

Who are Gondola Medical Technologies's competitors?

Companies similar to Gondola Medical Technologies include SOPHiA GENETICS, Pregnolia, and SmartGene.